Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Healthy

Interventions

DRUG

Drug

Single dose oral administration of CAT1004 or placebo-6 to 8 subjects will be treated with CAT-1004 per cohort.

OTHER

Placebo

Single dose oral administration of CAT1004 or placebo- 2 subjects treated with placebo per cohort.

Trial Locations (1)

Celerion Clinical Research Unit, Lincoln